Skip to main content
NCBI home page
Cancer Science logoLink to Cancer Science
. 2005 Aug 19;94(11):953–959. doi: 10.1111/j.1349-7006.2003.tb01384.x

Roles of luteinizing hormone/chorionic gonadotropin receptor in anchorage‐dependent and ‐independent growth in human ovarian surface epithelial cell lines

Hironori Tashiro 1, Hidetaka Katabuchi 1,✉, Monjura Begum 1, Xiaoguang Li 1, Makoto Nitta 1, Hideyuki Ohtake 1, Hitoshi Okamura 1
PMCID: PMC11160306  PMID: 14611671

Abstract

Epithelial ovarian carcinomas are thought to arise from cells of ovarian surface epithelium (OSE) covering the free surface of the human ovary. Two immortalized human cell lines, OSE2a (non‐tumorigenic) and OSE2b‐2 (tumorigenic), were previously established from normal OSE cells of a reproductive‐age patient. In the present study, we found that expression of luteinizing hormone (LH)/chorionic gonadotropin (CG) receptor (LH/CGR) is present in OSE2a cells and absent in OSE2b‐2 cells. In OSE2a cells, a low concentration (103 mlU/ml) of CG enhanced anchorage‐dependent growth via up‐regulation of insulin‐like growth factor‐1 (IGF1), whereas a high concentration (105 mlU/ml) of CG induced anchorage‐independent growth and down‐regulation of IGF1 expression. To investigate involvement of other genes in LH/CGR‐related tumorigenicity, we compared cDNA expression arrays of OSE2a and OSE2b‐2 cells, and found that the following genes had lower expression in OSE2b‐2 than in OSE2a: integrin β1, intercellular adhesion molecule‐1 (ICAM1), and Waf1/Cip1. Subsequent semiquantitative reverse transcription polymerase chain reaction using OSE2a cells showed that expression of integrin β1 was down‐regulated by a high concentration (105 mlU/ml) of CG. These results suggest that LH/CGR affects anchorage‐dependent and ‐independent growth by mediating up‐ and down‐regulation of IGF1 and integrin β1. Repetitive and excessive activation of LH/CGR may cause genetic alteration of its signal transduction pathway, resulting in stimulation of growth of OSE cells, initiation of ovarian carcinogenesis, and cancer progression.

References

  • 1. Scully RE. Ovarian tumors: a review. Am J Pathol 1977; 87: 686–720. [PMC free article] [PubMed] [Google Scholar]
  • 2. Okamura H, Katabuchi H, Nagai R. Ultrastructure of human ovulation: histofunctional parameters. In: Motta PM, editor Microscopy of reproduction and development. A dynamic approach. Rome : Antonio Delfino Editor; 1997. p. 155–61. [Google Scholar]
  • 3. Li AJ, Karlan BY. Genetic factors in ovarian carcinoma. Curr Oncol Rep 2001; 3: 27–32. [DOI] [PubMed] [Google Scholar]
  • 4. Tsao S‐W, Mok SC, Fey EG, Fletcher JA, Wan TSK, Chew E‐C, Muto MG, Knapp RC, Berkowitz RS. Characterization of human ovarian surface epithelial cells immortalized by human papilloma viral oncogenes (HPV‐E6E7 ORFs). Exp Cell Res 1995; 218: 499–507. [DOI] [PubMed] [Google Scholar]
  • 5. Auersperg N, Wong AST, Choi KC, Kang SK, Leung PCK. Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 2001; 22: 255–88. [DOI] [PubMed] [Google Scholar]
  • 6. Ong A, Maines‐Bandiera SL, Roskelley CD, Auersperg N. An ovarian adenocarcinoma line derived from SV40/E‐cadherin‐transfected normal human ovarian surface epithelium. Int J Cancer 2000; 85: 430–7. [PubMed] [Google Scholar]
  • 7. Nitta M, Katabuchi H, Ohtake H, Tashiro H, Yamaizumi M, Okamura H. Characterization and tumorigenicity of human ovarian surface epithelial cells immortalized by SV40 large T antigen. Gynecol Oncol 2001; 81: 10–7. [DOI] [PubMed] [Google Scholar]
  • 8. Rao BR, Slotman BJ. Endocrine factors in common epithelial ovarian cancer. Endocr Rev 1991; 12: 14–26. [DOI] [PubMed] [Google Scholar]
  • 9. Shushan A, Paltiel O, Iscovich J, Elchalal U, Peretz T, Schenker JG. Human menopausal gonadotropin and the risk of epithelial ovarian cancer. Fertil Steril 1996; 65: 13–8. [PubMed] [Google Scholar]
  • 10. Segaloff DI, Ascoli M. The lutropin/choriogonadotropin receptor: 4 years later. Endocr Rev 1993; 14: 323–47. [DOI] [PubMed] [Google Scholar]
  • 11. Gudermann T, Birnbaumer M, Birnbaumer L. Evidence for dual coupling of the murine luteinizing hormone receptor to adenylyl cyclase and phosphoinositide breakdown and Ca2+ mobilization. J Biol Chem 1992; 267: 4479–88. [PubMed] [Google Scholar]
  • 12. Ryu KS, Gilchrist RL, Koo YB, Ji I, Ji TH. Gene, interaction, signal generation, signal divergence and signal transduction of the LH/CG receptor. Int J Gynaecol Obstet 1998; 60: S9–20. [DOI] [PubMed] [Google Scholar]
  • 13. Wood JR, Strauss JF 3rd. Multiple signal transduction pathways regulate ovarian steroidogenesis. Rev Endocr Metab Disord 2002; 3: 33–46. [DOI] [PubMed] [Google Scholar]
  • 14. Rao CV. The beginning of a new era in reproductive biology and medicine: expression of low levels of functional luteinizing hormone/human chorionic gonadotropin receptors in nongonadal tissues. J Physiol Pharmacol 1996; 47: 41–53. [Google Scholar]
  • 15. Mandai M, Konishi I, Kuroda H, Fukumoto M, Komatsu T, Yamamoto S, Nanbu K, Rao CV, Mori T. Messenger ribonucleic acid expression of LH/hCG receptor gene in human ovarian carcinomas. Eur J Cancer 1997; 33: 1501–7. [DOI] [PubMed] [Google Scholar]
  • 16. Lu JJ, Zheng Y, Kang X, Yuan JM, Lauchlan SC, Pike MC, Zheng W. Decreased luteinizing hormone receptor mRNA expression in human ovarian epithelial cancer. Gynecol Oncol 2000; 79: 158–68. [DOI] [PubMed] [Google Scholar]
  • 17. Syed V, Ulinski G, Mok SC, Yiu GK, Ho SM. Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells. Cancer Res 2001; 61: 6768–76. [PubMed] [Google Scholar]
  • 18. Kuroda H, Mandai M, Konishi I, Tsuruta Y, Kusakari T, Kariya M, Fuji S. Human ovarian surface (OSE) cells express LH/hCG receptors, and hCG inhibits apoptosis of OSE cells via up‐regulation of insulin‐like growth factor‐1. Int J Cancer 2001; 92: 309–15. [DOI] [PubMed] [Google Scholar]
  • 19. Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case‐control studies; II. Invasive epithelial ovarian cancers in white women. Am J Epidemiol 1992; 136: 1184–203. [DOI] [PubMed] [Google Scholar]
  • 20. Franceschi S, La Vecchia C, Booth M, Tzonou A, Negri E, Parazzini F, Trichopoulos D, Beral V. Pooled analysis of 3 European case‐control studies of ovarian cancer: II. Age at menarche and at menopause. Int J Cancer 1991; 49: 57–60. [DOI] [PubMed] [Google Scholar]
  • 21. Fathalla MF. Incessant ovulation‐a factor in ovarian neoplasia Lancet 1971; 2: 163. [DOI] [PubMed] [Google Scholar]
  • 22. Resnicoff M, Ambrose D, Coppola D, Rubin R. Insulin‐like growth factor‐1 and its receptor mediate the autocrine proliferation of human ovarian carcinoma cell lines. Lab Invest 1993; 69: 756–60. [PubMed] [Google Scholar]
  • 23. Beck EP, Russo P, Gliozzo B, Jaeger W, Papa V, Wildt L, Pezzino V, Lang N. Identification of insulin and insulin‐like growth factor I (IGF I) receptors in ovarian cancer tissue. Gynecol Oncol 1994; 53: 196–201. [DOI] [PubMed] [Google Scholar]
  • 24. Conover CA, Hartmann LC, Bradley S, Stalboerger P, Klee GG, Kalli KR, Jenkins RB. Biological characterization of human epithelial ovarian carcinoma cells in primary culture: the insulin‐like growth factor system. Exp Cell Res 1998; 238: 439–49. [DOI] [PubMed] [Google Scholar]
  • 25. Zhou GF, Ye Feng, Cao LH, Zha XL. Overexpression of integrin α5β1 in human hepatocellular carcinoma cell line suppresses cell proliferation in vitro and tumorigenicity in nude mice. Mol Cell Biochem 2000; 207: 49–55. [DOI] [PubMed] [Google Scholar]
  • 26. Muller‐Klingspor V, Hefler L, Obermair A, Kaider A, Breitenecker G, Leodolte S, Kohlberger P. Prognostic value of β1‐integrin (=CD29) in serous adenocarcinomas of the ovary. Anticancer Res 2001; 21: 2185–8. [PubMed] [Google Scholar]
  • 27. Okamura H, Katabuchi H. Detailed morphology of human ovarian surface epithelium focusing on its metaplastic and neoplastic capability. Ital J Anat Embryol 2001; 106: 263–76. [PubMed] [Google Scholar]

Articles from Cancer Science are provided here courtesy of Wiley

RESOURCES